G
Graymatters
Biotech & Life Sciences · Haifa, Israel · Founded 2018
EEG-based self-neuromodulation therapy for mental health disorders MoreLess
Developer of digital therapeutics designed to cure mental illness. The company's digital therapeutics follow the self-regulation of brain processes to solve the issues related to mental health and neurologic disorder, enabling patients suffering from neurological disorders to treat their diseases in a hassle-free manner. Keywords: Pharmaceuticals and Biotechnology, Digital Therapeutics, Digital Therapeutics Software, Digital Therapy Platform, Eeg Biomarkers, Eeg Device, Eeg Equipment Software, Fmri Analysis, Healthcare Therapeutics Company, Machine Learning Technology, Therapeutics Device.
Company overview
Graymatters company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2018
- Headquarters
- Haifa, Israel
- Employees
- 31
- Open positions
- None listed
- Dealroom signal
- 66.0
Valuation & funding
Graymatters funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SUPPORT PROGRAM✓Other financing | Nov 2022 | $0 | — | Undisclosed | — |
| SUPPORT PROGRAM✓Other financing | Jan 2022 | $0 | — | 28DIGITAL Accelerator | — |
| SERIES A✓Equity / VC | Jan 2022 | $10M | $40M | Marius Nacht · J-Impact · Otsuka Pharmaceutical · Joyance Partners | ↗ |
| EARLY VC✓Equity / VC | Oct 2021 | $0 | — | EIC Fund | — |
| GRANT✓Other financing | Oct 2021 | $2.5M | — | European Innovation Council | — |
| SEEDEquity / VC | Mar 2020 | Joyance Partners | — | ||
| SPINOUT✓Other financing | Jan 2018 | Tel Aviv University · Tel Aviv Sourasky Medical Center | — |
Financials
Revenue and workforce over time
Available revenue and workforce history. Fields without reported data are omitted.
| Year | Revenue | Growth | Employees |
|---|---|---|---|
| 2026 | $2.4M | 0% | 31 |
| 2025 | $2.4M | 0% | 29 |
| 2024 | $2.4M | 0% | 27 |
| 2023 | $2.4M | +60% | 28 |
| 2022 | $1.5M | — | 18 |
| 2021 | — | — | 3,693 |
| 2020 | — | — | 3,693 |
Growth signals
Graymatters website traffic
Latest recorded traffic for Graymatters is 9.2K monthly website visits, up 196.8% over the last three months. Graymatters's team grew 6.9% over the past year.
Comparisons
Graymatters compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
 Restorative NeurotechnologiesProducing wearable medical device in order to enhance the strength of the rehabilitation for cognitive disease or enhance sport performance |
Palermo, Italy | Operational | 13 | $4.4M | $13M |
 moveUPAI-powered digital therapy for remote patient monitoring |
City of Brussels, Belgium | Operational | |||
 Mindable HealthDigital therapeutics for anxiety |
Berlin, Germany | Operational | |||
 CroivalveTreating Heart Valve Disease |
Dublin, Ireland | Operational | |||
 GlucosetIntravascular continuous glucose monitoring system for ICUs |
Trondheim, Norway | Operational | |||
 Aenitis TechnologiesDeveloping a cell treatment device |
Paris, France | Operational | |||
 NC BiomatrixDeveloping a patented injectable technology to improve the treatment of intervertebral disc degeneration |
Eindhoven, Netherlands | Operational | |||
 EverZomA key asset to the future health of an ageing population |
Paris, France | Operational |
Talent graph
Graymatters's talent
Source: Dealroom Talent Intelligence.
Investors
15 investors on Graymatters's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Graymatters has talent and traffic
team presence
In the news
Latest news about Graymatters
Recent press, funding announcements, and product moves mentioning Graymatters — open to read from the original sources.
Market sentiment
What the market is saying about Graymatters
An AI-synthesized read of the highest-engagement posts about Graymatters on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Graymatters’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.